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Abstract
Histamine is a monoaminergic neurotransmitter which is released within the entire
brain from ascending axons originating in the tuberomammillary nucleus in a sleep
state-dependent fashion. Besides the modulation of neuronal firing patterns, brain
histamine levels are also thought to modulate functions of glial cells. Microglia are
the innate immune cells and professional phagocytes of the central nervous system,
and histamine was previously shown to have multiple effects on microglial functions
in health and disease. Isolated microglia respond only to agonists of the Hrh2 subtype
of histamine receptors (Hrh), and the expression of that isoform is confirmed by a
metadata analysis of microglia transcriptomes. When we studied the effect of the
histamine receptor isoforms in cortical and thalamic microglia by in situ live cell Ca2+
imaging using a novel, microglia-specific indicator mouse line, microglial cells respond
to external histamine application mainly in a Hrh1-, and to a lower extent also in a
Hrh2-dependent manner. The Hrh1 response was sensitive to blockers of purinergic
P2ry12 receptors, and since Hrh1 expression was predominantly found in astrocytes,
we suggest that the Hrh1 response in microglia is mediated by astrocyte ATP release
and activation of P2ry12 receptors in microglia. Histamine also stimulates microglial
phagocytic activity via Hrh1- and P2ry12-mediated signaling. Taken together, we pro-
vide evidence that histamine acts indirectly on microglial Ca2+ levels and phagocytic
activity via astrocyte histamine receptor-controlled purinergic signaling.
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1 | INTRODUCTION
Histamine is a bioactive amine known to regulate many physiological
processes in the periphery, such as allergic reactions, gastric acid
secretion, and itch sensation (Thangam et al. (2018). In the central ner-
vous system (CNS), histamine is synthesized by L-histidine decarbox-
ylase (HDC)-expressing neurons which are localized in the
tuberomammillary nucleus (TMN) from where they send axonal pro-
jections towards essentially all brain (Haas & Panula, 2003; Panula &
Nuutinen, 2013). Histamine neurons are pacemakers that displayHelmut Kettenmann and Marcus Semtner should be considered shared senior author.
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regular spontaneous firing patterns at low frequency which are corre-
lated to sleep/wake rhythm with upregulation of histamine release
during wakefulness (Vitrac & Benoit-Marand, 2017). Abnormalities in
brain histamine release are increasingly appreciated as potential con-
tributors to brain pathologies like Parkinson's disease, Huntington's
disease, Alzheimer's disease, narcolepsy, and drug addiction (Panula &
Nuutinen, 2013).
Histamine action is mediated by signaling downstream of the four
mammalian histamine receptor isoforms (Hrh1-Hrh4) which are Gαq
(Hrh1), GαS (Hrh2), or Gαi (Hrh3 and Hrh4) protein-coupled receptors.
Recent transcriptomic and proteomic approaches suggest that there is—
if at all—only bare expression of Hrh4 in the central nervous system
(Zhang et al., 2014). The predominant isoform in the brain is Hrh3which
is mainly expressed by neurons and modulates the release of
various neurotransmitters, including GABA and acetylcholine (Passani
et al., 2000). Consistent with its abundance and strong impact on neuro-
transmitter release, Hrh3 is involved in diverse brain functions, such as
memory, cognition, appetite, and arousal. Hrh1 and Hrh2 are also
expressed by neurons at low levels, however, previous gene expression
studies and functional observations suggest that these subunits rather
serve as modulators of glial functions. Particularly, Hrh1, which is the
most abundant Hrh isoform in astrocytes, modulates various physiologi-
cal and pathological activities of astrocytes upon brain histamine level
changes including energy metabolism, neurotransmitter clearance, neu-
rotrophic activity, and immune responses (Jurič et al., 2016).
Microglia are the resident immune cells of the CNS. Their physio-
logical role is to protect the brain from infection and damage, to pro-
mote tissue repair and regeneration, and to modulate neurons and
other glial cells by secretion of growth factors, cytokines, and other
signal molecules (Wolf et al., 2017). In the healthy postnatal brain,
microglia are characterized by a ramified morphology, that is, they
have a relatively small soma (10 μm) with cellular processes that
branch off and arborize further more distantly from the soma within a
defined territory, and they constantly scan their environment for
potential insults (Kettenmann et al., 2011). Microglia are the profes-
sional phagocytes of the brain being able to eliminate entire cells or
cellular substructures. Microglia recognize cells that undergo
programmed cell death and they migrate to different regions of the
CNS, usually right before or during the peak of programmed cell death
(Wolf et al., 2017). The first report on histamine action on microglia
was from Bader et al. (1994) who demonstrated via life cell Ca2+
imaging that only a subpopulation of primary cultured rat microglia is
responsive to histamine application, a notion that was confirmed in a
more recent study on freshly isolated and primary cultured mouse
microglia (Pannell et al., 2014). Interestingly, the percentage of
histamine-responding microglia dramatically increases upon LPS chal-
lenge, indicating that microglia can dynamically adjust their sensitivity
to histamine, and suggesting that histamine action on microglia might
be heterogeneous with regard to certain physiological and pathophys-
iological conditions. There are various controversial results of micro-
glial Hrh expression and its functional impact. Indeed, histamine was
reported to stimulate microglial phagocytic activity in vitro and in situ
in a Hrh1-dependent manner (Rocha et al., 2016). Another study
demonstrated an inhibitory effect of histamine on microglial phagocy-
tosis in vitro via Hrh3 (Iida et al., 2015). Further controversy is about
microglial migration which was shown to be accelerated by histamine
in a Hrh4-dependent fashion and in another study inhibited by Hrh1
and Hrh2 (Apolloni et al., 2017). In the present study, we used a novel
microglia-specific Ca2+ indicator mouse model to investigate micro-
glial Ca2+ elevations upon histamine and Hrh-specific agonists in cor-
tex and thalamus. We provide evidence for functional Hrh2, but not
Hrh1, Hrh3, or Hrh4 expression on microglia and demonstrate that
Hrh1 in astrocytes and microglial P2ry12 are involved in histamine
action on microglia in situ.
2 | MATERIALS AND METHODS
2.1 | Animals
This study was carried out at the Max Delbrück Center for Molecular
Medicine (MDC) in strict accordance with the guidelines of the
European Communities Council Directive for care of laboratory ani-
mals (86/609/EEC) and of the State of Berlin's Office for Health and
Social Affairs (Landesamt für Gesundheit und Soziales, LaGeSo), as
well as internal MDC guidelines. Experimental protocols were
approved under license (X9005/18, X9023/12, A0376/17). Animals
were bred and maintained at the MDC animal facility in a
temperature- and humidity-controlled environment with a 12 h light–
dark cycle and ad libitum access to food and water. The mouse strains
Csf1R-2A-GCaMP6m and Csf1R-2A-mCherry-2A-GCaMP6m are
novel, microglia-specific calcium indicator lines which are described in
another paper from our lab (Logiacco et al., in press). hGFAP-mRFP
transgenic mice express the red fluorescent protein (mRFP) in astro-
cytes under control of the promotor for human glial fibrillary acidic
protein (GFAP) (Hirrlinger et al., 2005). We pooled male and female
mice in all experiments.
2.2 | Chemicals
The following substances were used in the present study: histamine
dihydrochloride (Sigma-Aldrich; 100 μM), 2-pyridylethylamine
dihydrochlid (2-PEA; R&D Systems; 100 μM), amthamine (Enzo;
10 μM), α-methylhistamine (αMH; Biomol; 1 μM), VUF 10460
(Biomol; 10 μM), cetirizine (Sigma-Aldrich; 10 μM), Tiotidine (R&D
Systems; 10 μM), carcinine (Sigma-Aldrich; 10 μM),, AR-C69931
tetrasodium salt (Tocris, Bio-Techne GmbH, Wiesbaden-Nordenstadt;
1 μM). All chemicals were obtained as powder and initially stock-
diluted at a 1,000 fold concentration in DMSO or H2O.
2.3 | Acute brain slice preparation
Acute cortical brain slices from adult male and female C57BL/6,
Csf1R-2A-GCaMP6m or Csf1R-2A-mCherry-2A-GCaMP6m mice
2292 XIA ET AL.
(P40–P90) were prepared as previously described (Boucsein
et al., 2003). In brief, adult mice were killed by cervical dislocation.
After the brain was extracted, the cerebellum and the olfactory bulbs
were gently removed and transferred to ice-cold slicing solution
(230 mM sucrose, 26 mM NaHCO3, 2.5 mM KCl, 1.25 mM NaH2PO4,
10 mM MgSO4, 0.5 mM CaCl2, 10 mM D-glucose; pH 7.4; saturated
with carbogen: 95% O2, 5% CO2) to generate 140 μm (phagocytosis
assay) or 250 μm (Ca2+ imaging) thick coronal slices using a vibratome
(HM650V, Thermo Scientific). Slices were immediately transferred
into artificial cerebrospinal fluid (ACSF): 134 mM NaCl, 26 mM
NaHCO3, 2.5 mM KCl, 1.26 mM K2HPO4, 1.3 mM MgCl2, 2 mM
CaCl2, 10 mM D-glucose; pH 7.4 which was saturated with carbogen
(95% O2, 5% CO2) at room temperature. The brain slices were kept in
ACSF at least 1 h until further treatment.
2.4 | Preparation of freshly isolated microglia
Microglia from adult C57BL/6 mice (P49–P90) were acutely isolated
and purified for calcium imaging using magnetic-activated cell sorting
(MACS) as described previously (Nikodemova & Watters, 2012).
Briefly, adult mice were sacrificed by transcardial perfusion with ice-
cold phosphate-buffered solution (PBS) under deep anesthesia to
remove the blood. The brain was removed and only the cortex was
dissected into Miltenyi Biotec adult brain Dissociation Kit (Trypsin)
and dissociated in the gentleMACS Octo Dissociator with heaters
(Miltenyi Biotech) for 30 min. After dissociation, the suspension was
passed through a MACS SmartStrainer (70 μm) followed by centrifu-
gation for 1 min at 300 g and 4C to obtain a single cell suspension.
The cell suspension was then homogenized and resuspended in debris
removal solution (Miltenyi Biotech). A layer of PBS was very gently
applied on top and centrifuged at 3000g, 4C for 10 min with full
acceleration and full brake. The cells were washed and resuspended in
MACS-buffer (PBS, 0.5% bovine serum albumin, 2 mM EDTA) and sta-
ined with CD11b magnetic Microbeads (Miltenyi Biotech) at 4C for
15 min. Labeled CD11b-positive cells (microglia) within the large-sized
MACS column were then flushed out and plated onto glass coverslips,
followed by incubation in DMEM (Invitrogen, Karlsruhe, Germany)
medium for at least 2 h to allow adherence. Ca2+ imaging was subse-
quently carried out as described below.
2.5 | Calcium imaging
Acutely isolated microglial cells were plated on glass coverslips.
After 2 h, adhered microglia were incubated for 40 min with 5 μM
Fluo-4/AM (Invitrogen) in standard extracellular solution (150 mM
NaCl, 5.4 mM KCl, 0.98 mM MgCl2, 1.97 mM CaCl2, 10 mM
HEPES, and 10 mM glucose; pH 7.4) at room temperature. Acute
brain slices from Csf1R-2A-GCaMP6m mice were only maintained
in carbogenized ACSF at RT, while slices (250 μm) from C57/Bl6
mice were generated and loaded with 10 μM Fluo4/AM for 1 h at
37C to stain astrocytes.
Coverslips or brain slices were transferred into a recording cham-
ber constantly perfused with standard extracellular solution (isolated
microglia) or carbogenized ACSF (brain slices). The perfusion system
was equipped with a perfusion pencil which allowed instant and local
application of the test substances, as well as 1 mM ATP (Adenosine-
Triphosphate) applied at the end of every recording as control. The
flow of the perfusion system was adjusted to 0.5–0.6 ml/min. Before
live cell Ca2+ imaging, each brain slice/coverslip was first examined
using a 5X objective and bright field illumination. For Ca2+ recordings,
we used a 20 objective (Carl Zeiss Microscopy GmbH), a Zyla 5.5
camera (Oxford Instruments), a light-emitting diode illuminator (pE-
4,000, CoolLED, Andover, UK) and a standard EGFP filter set. An
EPC9 amplifier (HEKA) and TIDA 5.25 software (HEKA) were used to
trigger fluorescence excitation and image acquisition. To monitor Ca2
+ level changes over time, images were taken at a rate of 1 frame per
second and an exposure time of 100 ms. For experiments at 37C, we
used an inline heater (Warner Instruments Corp.).
For 2-Photon imaging, we used a custom-built 2-photon micro-
scope consisting of an BX61WI microscope stage (Olympus) equipped
with a 40 water immersion objective placed on a PD72Z4CA piezo
drive (Physik Instrumente), a Chameleon Ultra II laser (Coherent) and
GaAsP photomultipliers (Thorlabs). The GCaMP6m protein was excited
at a wavelength of 940 nm. Movies were acquired at a sampling rate of
one 3D image per second, whereas each 3D image covered seven fields
of 160  160 μm with a z distance of 2 μm (i.e., total z distance:
40 μm). ThorImage 8.0 was used to drive the image acquisition during
calcium imaging experiments. For offline analysis, each 3D image was
subjected to a maximum intensity projection to obtain a 2D movie by
using a custom-built procedure in IGOR Pro 6.37 (WaveMetrics). Cal-
cium imaging movies were analyzed using a home-made algorithm in
Igor Pro 6.37 (WaveMetrics). For analysis, cell somata which were visi-
ble in the presence of ATP at the end of each experiment were selected
as ROIs, and the mean relative fluorescence intensity for each ROI and
frame was determined to display changes in Ca2+ levels over time for
each cell. This means that only ATP-responding microglia/astrocytes
were taken into the subsequent analysis. Intracellular Ca2+ elevations
were counted as “responsive” upon application of a substance when
the Ca2+ response amplitude exceeded a level three times (microglia) or
five times (astrocytes) the SD from the baseline that was obtained in
the 60 s immediately before application. We averaged the cellular
response rates from each slice to obtain one “n” for the subsequent sta-
tistical analysis. Recordings with less than five microglia in the view field
were excluded from analysis. For the analysis of amplitudes and kinetics
of microglial Ca2+ responses as well as for averaging histamine
responses in the figures (stated as “responding”), we used only
“responding” events and excluded non-responders.
2.6 | In situ phagocytosis assay
Phagocytosis assay in acute cortical or thalamic brain slices was con-
ducted as previously described (Wendt et al., 2017). Briefly, coronal
brain slices from C57/Bl6 mice were generated and maintained for
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2 h at RT in ACSF to recover from the slicing procedure (see above).
Subsequently, slices were incubated at 37C for 1 h with latex beads
(4.5 μm diameter, Polysciences, Hirschberg Germany), either only in
ACSF or together with the specified histamine or isoform-specific
agonists and antagonists; then washed three times in 0.1 M PBS
(20 min), fixed with 4% paraformaldehyde for 1 h for subsequent
staining and again washed three times in 0.1 M PBS (20 min each).
For staining, slices were incubated for 4 h at room temperature in a
permeabilization buffer containing 2% Triton X-100 (Carl Roth), 2%
bovine serum albumin (Carl Roth), 10% normal donkey serum (EMD
Millipore) in 0.1 M PBS (pH 7.4) and then overnight incubated with a
goat anti-Iba1 antibody (1:600; clone #5076 Abcam) in dilution buffer
(1:10 of permeabilization buffer in 0.1 M PBS) at 4C. On the next
day, slices were incubated for 2 h with the secondary antibody don-
key anti-goat Alexa Fluor 647 (1:250; Dianova). After washing, the
slices were mounted on glass slides with Aqua Polymount mounting
medium (Polysciences). Confocal laser scanning microscopy was per-
formed on a Leica TCS SPE confocal microscope (Leica) using a 20
oil immersion objective. We acquired 21 μm thick z-stacks at 1.05 μm
intervals beginning from the surface of the slice.
Data analysis to assess microglial phagocytic activity was per-
formed using Imaris 6.3.1 (Bitplane). The Iba1-positive volumes of
high-resolution SPE confocal microscopy stacks were 3D surface ren-
dered using a software-internal threshold value of 40 AU and a back-
ground subtraction (software-internal parameters: 1–3 times, 90 μm
each). Microspheres were detected as spots and counted. All beads
having their center located within a given rendered Iba1 volume were
considered to be phagocytosed by microglia. The phagocytic index
was calculated as: nPM*10
4/VIba1 (nPM is the total number of phagocy-
tosed microspheres and VIba1 is the Imaris-rendered volume of Iba1
fluorescence in μm3). Igor Pro 6.37 (WaveMetrics) and Prism 7 (Gra-
phPad Software) were used for subsequent statistical analysis.
2.7 | Metadata analysis
The cell-type-specific expression of Hrh isoforms was obtained directly
from the website www.brainrnaseq.org. Single FPKM values were com-
piled in IGOR Pro 6.37 and plotted as heat map (Figure S1A; Zhang
et al., 2014). For looking into the brain region-specific microglial RNAseq
dataset at different ages (Grabert et al., 2016), the normalized data set
GSE62420 was downloaded from the GEO site (https://www.ncbi.nlm.
nih.gov/geo/), and FPKM values of each sample were normalized to the
expression of Hprt for a proper comparison between different brain
regions. Hrh and P2ry12 values were finally compiled in IGOR Pro 6.37
and plotted as heat map. For Hrh and P2ry12 expression in single
microglia (Tabula Muris Consortium, 2018), we utilized the online tools on
https://tabula-muris.ds.czbiohub.org/ and exported the resulting plots.
2.8 | Statistical analysis
All data represent the percentage of microglia responding in each
brain region from at least three animals per experimental condition.
We applied the Kruskal-Wallis followed by a Dunn's multiple compari-
son test to calculate significance levels between data sets. Data are
given as median ± 25%/75% percentile. Statistical significance levels
are represented as n.s.: p > .05; *: p < .05; **: p < .01; ***: p < .001.
3 | RESULTS
3.1 | Microglial histamine responses are mediated
by Hrh2 receptors
Microglia were previously shown in vitro to functionally express hista-
mine receptors that mediate downstream cytosolic Ca2+ elevations
(Pannell et al., 2014). We revisited these findings and determined his-
tamine responses in freshly isolated cortical microglia from C57/Bl6
mice which were loaded with Fluo4/AM to indicate intracellular Ca2+
level changes (Figure 1a,b). ATP (1 mM) was applied at the end of
each recording and only ATP-responding cells were considered for
the subsequent analysis. As microglia are known to display spontane-
ous Ca2+ elevations (Korvers et al., 2016), we first determined the
probability of spontaneous events within a minute before histamine
application which was observed in 1.13 ± 0/3.39% of the cells
(n = 3,028 isolated cells, 54 recordings, 11 mice). In accordance with
our published data set, a subpopulation (5.88 ± 2.98/8.00%; n = 502
cells, 15 recordings, 4 mice) of these microglial cells responded to his-
tamine which was a significantly higher rate than spontaneous Ca2+
elevations before histamine application (p = .0021). Microglial Ca2+
responses to histamine had a peak of 0.72 ± 0.16 relative to the
responses upon ATP; they were transient and completely reversed to
background levels upon wash out.
In the mammalian genome, there are four known histamine receptor
isoforms (Hrh1-4; Passani et al., 2000). In an attempt to identify the
receptor isoform responsible for microglial histamine responses, we used
Hrh isoform-specific agonists. As shown in Figure 1c,d, freshly isolated
microglia selectively responded to the Hrh2-specific agonist amthamine
(10 μM). 4.17 ± 2.38/11.83% of the ATP-responding isolated microglia
displayed amthamine-evoked Ca2+ elevations (n = 1,345 cells, 25
recordings, 7 mice) which was similar to the histamine-responding popu-
lation (5.88 ± 2.98/8.00%; p = .9999) and significantly more than the
level of spontaneously active cells (p = .0016). Hrh1 activation by
2-pyridylethylamine dihydrochlid (2-PEA; 100 μM) did, however, not
stimulate Ca2+ elevations in freshly isolated microglia as the response
rate was similar to basal activity (2 ± 0.37/3.75%; n = 962 cells, 15
recordings, 5 mice; p = .9999). There was also no response to Hrh3 and
Hrh4 activation by α-Methylhistamine (αMH; 1 μM) and VUF 10460
(VUF; 10 μM), respectively (Figure 1d). We therefore conclude that
microglia express Hrh2 receptors which mediate intracellular Ca2+ eleva-
tions upon histamine application. This conclusion is strongly supported
by previously published transcriptomic expression profiles of microglia
and other brain cell types. A meta-analysis of several data sets
(Figure S1) revealed that indeed hrh2 is the predominant isoform in
microglia whereas hrh1 is mainly expressed by astrocytes and hrh3 by
neurons (Zhang et al., 2014). Specific expression of hrh2 in microglial
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cells was also confirmed in many other transcriptomic data sets including
the one provided by Grabert et al. (2016); Figure S1B), the Tabula Muris
Consortium (2018); Figure S1C), Bowman et al. (2016)) and Sala Frigerio
et al. (2019)). Taken together, both transcriptomic analysis and live cell
investigation of isolated microglia support the notion that Hrh2 is the
only histamine receptor isoform expressed intrinsically in microglial cells
and mediates microglial Ca2+ responses upon histamine stimulation.
3.2 | A subpopulation of microglia responds to
histamine in different brain regions
We applied our novel transgenic Ca2+ indicator mouse model
(Logiacco et al., in press), Csf1R-2A-GCaMP6m to test for microglial
histamine responses in situ. In this mouse model, a transgenic
gcamp6m cassette preceded by a 2A sequence is introduced right
before the stop codon of the endogenous Csf1r gene, leading to the
expression of the Ca2+ indicator protein GCaMP6m specifically in
microglia. Acute cortical brain slices were generated from adult (P40–
P90) male and female indicator mice to monitor microglial intracellular
Ca2+ responses upon bath application of histamine (100 μM) using
live-cell imaging (Figure 2a). In accordance to our observations in
Logiacco et al. (in press), the intensity of the GCaMP6m fluorescence
under basal conditions was very low in this mouse model, and the
fluorescence within microglia was nearly indistinguishable from back-
ground fluorescence. Microglial cells undergoing intracellular Ca2+
elevations, however, display strong enhancements in GCaMP6m fluo-
rescence (see Figure 1a). Like in vitro experiments (see Figure 1),
F IGURE 1 Freshly isolated cortical microglia respond to histamine via Hrh2 activation. (a) Top, representative images from live-cell recordings on adult
isolated microglial cells in the presence of histamine (left) and ATP (right). Isolated microglia were obtained from C57/Bl6 cortex via MACS (CD11b) and
loaded with Fluo4/AM before recordings. Images were generated by subtraction of the movie frames before substance application from frames in the
presence. Histamine-responding microglia are indicated with a yellow arrow, non-responding microglia with a white arrow. Bottom, overlay of intracellular
Ca2+ responses from cortical histamine-responding microglia. The black trace is the average response of all responding cells (gray). (b) Left, percentage of
freshly isolated microglia responding spontaneously or upon histamine application. Right, Average amplitudes of microglial histamine responses normalized
to the amplitude of ATP responses. (c) Overlay of intracellular Ca2+ responses from microglia in response to histamine (100 μM, left) and amthamine (Hrh2
agonist; 10 μM, right). The black trace is the average response of all responding cells (gray). (d) Summary of microglia Ca2+ responses upon histamine
(100 μM), 2-PEA (Hrh1 agonist; 100 μM), amthamine (Hrh2 agonist; 10 μM), α-methylhistamine (αMH; Hrh3 agonist; 1 μM) or VUF 10460 (VUF; Hrh4
agonist; 10 μM) and under basal conditions. Note that only Hrh2 activation evoked microglial Ca2+ responses similar to histamine. Significance statement
above the bars is from comparison against basal conditions. Box Plots indicate the median (black line) as well as the 25%–75% (box) and 10%–90%
(whiskers) percentiles. Statistical significance was tested by a Kruskal-Wallis test followed by Dunn's multiple comparisons test and is indicated as
followed: n.s., p ≥ .05; *p ≤ .05; **p ≤ .01, ***p ≤ .001. Number of mice/experiments/cells: N(basal) = 11/54/3028; N(histamine) = 8/15/502; N(2-
PEA)= 5/15/962; N(amthamine)= 7/25/1345; N(αMH)= 2/5/120; N(VUF)= 1/4/144
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F IGURE 2 Cortical microglia in situ respond to histamine via Hrh1 and Hrh2. (a) Top, representative microglial cells during live cell recordings
from adult cortical brain slices in the presence of histamine (left) and ATP (right). Images were generated by subtraction of the movie frames
before substance application from frames in the presence. Histamine-responding microglia are indicated with a yellow arrow, non-responding
microglia with a white arrow. Bottom, overlay of intracellular Ca2+ responses to histamine from cortical microglia. The black trace is the average
response of all responding cells (gray). (b) Summary of the percentage of histamine-responding microglia in situ (left). Average amplitudes of
microglial histamine responses normalized to the amplitude of ATP responses (right). (c). Representative microglial cell during a 2-photon live-cell
recording from an adult cortical brain slice in the presence of histamine (left) and ATP (right). Images were generated by subtraction of the movie
frames before substance application from frames in the presence. Note that only proximal processes responded to ATP and histamine. (d)
Intracellular Ca2+ responses from cortical histamine-responding microglia. Regions of interest of the traces are indicated by arrows in (c). (e)
Overlay of intracellular Ca2+ responses from in situ cortical microglia responding to histamine, a Hrh1- (2-PEA, 100 μM) and a Hrh2- (Amthamine;
10 μM) specific agonist. Black traces indicate the average response of all responding cells (gray). (f) Summary of the percentage of responding
microglia from experiments shown in (c), including those with Hrh3- (α-methylhistamine; 10 μM) and Hrh4- (VUF 10460; 10 μM) specific agonists.
Box Plots indicate the median (black line) as well as the 25%–75% (box) and 10%–90% (whiskers) percentiles. Statistical significance was tested
by a Kruskal Wallis test followed by Dunn's multiple comparisons test and is indicated as followed: n.s., p ≥ .05; *p ≤ .05; **p ≤ .01, ***p ≤ .001.
Number of mice/experiments/cells: N(basal) = 16/143/1296; N(histamine) = 11/45/747; N(2-PEA) = 4/24/167; N(amthamine) = 4/24/184; N
(αMH) = 6/29/346; N(VUF) = 6/30/364; N(basal 37C) = 4/19/261; N(histamine 37C) = 4/21/272
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histamine in situ also induced Ca2+ elevations only in a subset of
microglia (Figure 2b) with 12.1 ± 5.3%/20.0% of ATP-responding cells
being also responsive for histamine (n = 747 cells, 45 slices, 11 mice).
The subpopulation of histamine-responding microglia was significantly
larger in situ than in vitro (p = .0105). There were no significant differ-
ences between microglial responses from male and female brain slices
(p = .0657). Histamine responses were often biphasic with a fast ini-
tial, transient rise and a second, sustained phase which reversed to
baseline Ca2+ levels upon wash out of histamine (Figure 2a). The peak
amplitude of the initial intracellular Ca2+ rise was on average 57.7
± 5.9% of the ATP-evoked Ca2+ elevation. We also quantified the
percentage of cells that responded randomly within a 60 s period
before histamine application. 0.0 ± 0.0/0.0% of the ATP-responding
microglia displayed this spontaneous activity indicating that histamine
induced a significant response over baseline activity (p < .0001). There
were no significant differences in basal (p = .3226) or histamine
(p > .9999) responses when experiments were performed at 37C
(Figure 2b). We next investigated if microglial histamine responses are
also abundant in processes. As shown in Figure 2c,d, Ca2+ responses
upon ATP application were, if at all, only found in the proximal parts
of microglial processes. On average, 1.46 ± 0.31 (proximal) processes
per microglia responded to ATP. We quantified the process Ca2+ sig-
nals upon histamine in microglia that displayed a somatic histamine
response and found that the majority of ATP-responding processes
(73.7%) did also respond to histamine. These data demonstrate that
microglial Ca2+ responses to ATP and histamine are much more pro-
nounced in somata than processes.
We next addressed the question if there is brain region-specific
heterogeneity in microglial histamine responses and performed in situ
live cell recordings in hippocampus, striatum, thalamus, and corpus
callosum. As shown in Figure S2, microglia responded also in these
brain regions upon application of 100 μM histamine. The proportion
of histamine-responding microglia was comparable to cortex in hippo-
campus (7.3 ± 0.0/20.0%; n = 320 cells, 46 slices, 10 mice; p > .9999),
F IGURE 3 Astrocytes in cortex and thalamus respond to histamine via Hrh1. (a) Representative astrocytes from cortex during live cell imaging
recordings from adult brain slices in the presence of the Hrh1-specific agonist 2-PEA. Slices were loaded with 10 μM Fluo4/AM to record
astrocytic Ca2+ level changes. Images were generated by subtraction of the movie frames before substance application from frames in the
presence. Traces on the right show the overlay of intracellular Ca2+ responses from cortical histamine- or 2-PEA-responding astrocytes. Black
traces indicate the average response of all responding cells (gray). (b) Summary of the percentage of histamine-, 2-PEA (Hrh1 agonist)- and
amthamine (Hrh2 agonist)- responding astrocytes in cortical slices. (c) and (d) Same as (a) and (b) but data were obtained from in situ recordings in
the thalamus. Box plots indicate the median (black line) as well as the 25%–75% (box) and 10%–90% (whiskers) percentiles. Statistical significance
was tested by a Kruskal Wallis test followed by Dunn's multiple comparisons test and is indicated as followed: n.s., p ≥ .05; *, p ≤ .05; **, p ≤ .01;
***, p ≤ .001. Number of mice/experiments/cells: N(Cx basal) = 3/10/124; N(Cx histamine) = 4/11/143; N(Cx 2-PEA) = 3/10/124; N(Cx
amthamine) = 3/11/129; N(Tha basal) = 4/47/457; N(Tha histamine) = 2/16/168; N(Tha 2-PEA) = 2/13/133; N(Tha amthamine) = 4/16/147
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striatum (0.0 ± 0.0/12.5%; n = 238 cells, 39 slices, 12 mice,
p = .0904), thalamus (25.0 ± 11.9/45.8%; n = 253 cells, 37 slices, 12
mice; p = .1611) and corpus callosum (22.5 ± 5.8/52.1%; n = 323
cells, 36 slices, 12 mice; p = .3635). Significant differences were found
between hippocampus and striatum in which microglia responded to a
lesser extend to histamine than in thalamus (p = .0023 vs. HC;
p < .0001 vs. Str) and in the corpus callosum (p = .0105 vs. HC;
p < .0001 vs. Str).
Taken together, we conclude from these experiments that a sub-
population of microglia responds to histamine in vitro and in situ, and
that the percentage of histamine-responding microglia varied among
different brain regions.
3.3 | Microglial histamine responses in situ are
mediated by Hrh1 and Hrh2
We next performed in situ Ca2+ recordings on cortical microglia using
Hrh isoform-specific agonists (Figure 2c,d). Surprisingly, application of
the Hrh1-specific agonist 2-pyridylethylamine dihydrochlid (2-PEA;
100 μM) led to microglial Ca2+ elevations in 13.4 ± 0.0/25.6% of cortical
microglia (n = 184 cells, 24 slices, 4 mice) which was not significantly dif-
ferent to the response rate upon 100 μM histamine (p > .9999).
Amthamine (10 μM), which specifically activates Hrh2 receptors, evoked
also Ca2+ responses in 4.6 ± 0.0/17.1% of the microglia (n = 184 cells,
24 slices, 4 mice) which was still higher than spontaneous activity
(p = .0440) and not different from histamine (p = .4190). The Hrh3- and
Hrh4-specific agonists αMH (1 μM) and VUF 10460 (10 μM) did not
evoke Ca2+ responses in cortical microglia.
We aimed at verifying these results in another brain region and
investigated microglial Ca2+ responses upon Hrh isoform-specific agonists
in the thalamus (see Figure S3). Like in the cortex, there was a significant
portion of microglia (18.2 ± 9.6/34.1%; n = 396 cells, 43 slices, 6 mice)
responding to the Hrh1-specific agonist 2-PEA (100 μM) which was simi-
lar to thalamic responses upon histamine (p > .9999; Figure S3A,B). The
Hrh2-specific agonist amthamine also evoked Ca2+ responses in a subset
of ATP-responding microglia (13.4 ± 8.3/19.6%; n = 354 cells, 34 slices, 6
mice; p > .9999). Isoform-specific activation of Hrh3 (0.0 ± 0.0/5.4%;
n = 223 cells, 34 slices, 6 mice) or Hrh4 (0.0 ± 0.0/0.0%; n = 275 cells, 37
slices, 6 mice) did not have significant effects on microglial Ca2+ levels in
thalamus when compared with spontaneous baseline activity. To further
validate these results, we tested microglial histamine responses in thala-
mus in the presence of Hrh-isoform-specific blockers (Figure S3). Strik-
ingly, the Hrh1-specific antagonist cetirizine (10 μM) significantly
decreased microglial Ca2+ responses upon histamine application (0.0
± 0.0/14.9%; n = 244 cells, 32 slices, 5 mice; p < .0001). Antagonizing
Hrh2 by using tiotidine (10 μM) did not significantly affect histamine
responses of thalamic microglia (15.5 ± 7.9/26.7%; n = 425 cells
from 38 slices and 6 mice; p > .9999). Likewise, Hrh3 (carcinine;
10 μM) had no significant effects on microglial histamine responses
(18.33 ± 0/34.37%; n = 358 cells, 40 slices, 6 mice; p = > .9999;
Figure S3A,B). Taken together, our data indicate the involvement of
Hrh1 and Hrh2 in microglial histamine responses in cortex and thala-
mus, with Hrh1 being more predominantly involved. These findings
are in contrast to our data on isolated microglia demonstrating that
Hrh2 is the only microglia-intrinsic histamine receptor opening the
possibility that the microglia Hrh1-mediated response could be indi-
rect and mediated by another cell type.
F IGURE 4 Histamine-evoked microglial Ca2+ responses depend on P2ry12. (a) Left, overlay of intracellular Ca2+ responses from in situ
cortical microglia responding to histamine in the presence or absence of the P2ry12 inhibitor AR-C69931 (1 μM). Black traces indicate the
average response of all responding cells (gray). Note that unlike in the other figures, both responding and non-responding traces are shown in
these plots. Right, summary of the percentage responding microglia from experiments shown in (a). (b) Same as (a) but data were obtained from
thalamic microglia in situ. Box plots indicate the median (black line) as well as the 25%–75% (box) and 10%–90% (whiskers) percentiles. Statistical
significance was tested by a Kruskal Wallis test followed by Dunn's multiple comparisons test and is indicated as followed: n.s., p ≥ .05; *, p ≤ .05;
**, p ≤ .01, ***p ≤ .001. Number of mice/experiments/cells: N(Cx basal) = 16/143/1296; N(Cx histamine) = 11/45/747; N(Cx ARC basal) = 4/22/
555; N(Cx ARC histamine) = 4/23/590; N(Tha basal) = 39/229/2250; N(Tha histamine) = 13/47/613; N(Tha ARC basal) = 4/20/393; N(Tha
ARC histamine) = 4/16/147
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3.4 | Hrh1-mediated microglial Ca2+ responses are
indirectly mediated via astrocytes
Astrocytes express Hrh1 receptors (Zhang et al., 2014) and were pre-
viously shown to respond with Ca2+ elevations to histamine via Hrh1
(Jung et al., 2000). It suggests that they could be a potential source
for signaling substances that are released in a histamine (Hrh1)-
dependent fashion from astrocytes and sensed by microglia. We revisited
the previous findings and studied astrocytic Ca2+ level changes in
response to histamine in situ. AM-ester-coupled Ca 2+ indicators are usu-
ally nicely taken up by cultured or isolated microglia (e.g., Elmadany, de
Almeida Sassi, et al., 2020; Hoffmann et al., 2003; Moller et al., 2000),
however, in brain slices taken up mainly by astrocytes (Schipke
et al., 2002). We confirmed this previous finding by comparing Fluo4/AM
labeling with fluorescence reporter expression in acute brain slices from
GFAP-RFP mice. As shown in Figure S6, Fluo4/AM signals largely over-
lapped with RFP fluorescence (95.9 ± 3.9%), indicating that the Ca2+ indi-
cator was taken up by GFAP+ cells, putatively astrocytes. In fact, this
finding does not exclude non-astrocytic cells types with a similar morphol-
ogy like NG2 cells. However, NG2 glia usually do not express GFAP
(Dawson, 2003) and contribute to a rather low extent (2%–3%) to the cell
population of the CNS as compared with GFAP+ astrocytes (10%–15%).
We therefore conclude that the majority of the Fluo4-labelled cells in our
slices are astrocytes and we used this Ca2+ indicator for loading cortical
brain slices from C57/Bl6 mice. As shown in Figure 3a,b,
76.5 ± 52.5/87.9% of the cortical ATP-responding cells displayed Ca2+
elevations upon external application of 100 μM histamine (n = 143 cells,
11 slices, 3 mice) which was significantly more than basal, spontaneous
astrocytic Ca2+ elevations (0.0 ± 0.0/6.4%; p = .0002). We did the same
experiment in cortical slices from Csf1r-2A-mCherry-2A-GCaMP animals
(Figure S7) and discriminated microglia by their transgenic mCherry fluo-
rescence from astrocytes (mCherry-). The response rate of the mCherry+
cells was comparable to that of microglial cells in Figure 2 (12.5 ± 5.8/
20.6%; n = 160 cells, 12 slices, 4 mice) and was significantly smaller than
the response rate of mCherry- cells (64.6 ± 42.6/88.8%; n = 158 cells, 14
slices, 4 mice).
The application of 2-PEA (Hrh1 agonist; 100 μM) led to compara-
ble astrocytic Ca2+ responses (80.0 ± 66.7/88.9%; n = 124 cells, 10
slices, 3 mice; p = .0013 vs. basal and p = .0013 vs. histamine),
suggesting that Hrh1 is the dominant histamine receptor isoform in
cortical astrocytes. The astrocytic response rate upon the Hrh2-
specific agonist amthamine was 6.5 ± 0.0/20.5% (n = 129 cells, 11
slices, 3 mice) which was not significantly different from basal activity
(p > .9999). We also investigated thalamic astrocytes and found—
similar to cortical astrocytes—the majority of cells responding to hista-
mine (70.7 ± 32.1/82.7%; n = 168 cells, 16 slices, 2 mice; Figure 3c,d)
and Hrh1 stimulation (2-PEA; 60.0 ± 39.7/79.7%; n = 133 cells, 13
slices, 4 mice; p > .9999 vs. histamine) whereas there was no response
upon Hrh2 activation (amthamine; 0.0 ± 0.0/0.0%; n = 147 cells, 16
slices, 4 mice; p < .0001 vs. histamine).
We therefore conclude that astrocytes express functional Hrh1
receptors in cortex and thalamus being, thus, potential sources of a
Hrh1-dependent secondary signaling toward microglial receptors.
3.5 | Microglia Ca2+ responses to histamine are
dependent on P2ry12 signaling
It has been previously shown that purinergic signaling is a strong com-
munication pathway between astrocytes and microglia, and that astro-
cytic Ca2+ elevations can be followed by ATP release and subsequent
microglial Ca2+ responses (Schipke et al., 2002; Verderio &
Matteoli, 2001). The data above demonstrate that astrocytes but not
microglia respond to Hrh1 stimulation. In an attempt to test for the
hypothesis that Hrh1 stimulation indirectly mediates microglial Ca2+
responses via astrocytes and ATP release, we blocked P2ry12 which is
specifically expressed by microglia in the brain, and which is the pre-
dominant (metabotropic) purinergic receptor in microglia (Figure 4a,b).
Cortical brain slices from microglia Ca2+ indicator mice were incu-
bated for 2 min with AR-C69931 (1 μM) prior to the application of
histamine (100 μM). The blockade of P2ry12 dramatically reduced
microglial histamine responses to levels indistinguishable from base-
line activity: only 2.70 ± 0/3.72% of ATP-responding microglia dis-
played histamine responses in the presence of AR-C69931 (n = 590
cells, 23 slices, 4 mice; p = .6808 vs. basal and p = .0012 vs. hista-
mine/control), suggesting that ATP is the messenger that causes corti-
cal microglial Ca2+ responses upon histamine application. Microglia
histamine responses were also inhibited in thalamus, however, to a
lower extent. In the presence of AR-C69931, 12.0 ± 4.6/16.9% of the
microglia responded upon histamine application (n = 393 cells from
20 slices and 4 mice). This was not significantly different from sponta-
neous activity (0.0 ± 0.0/1.1%, p = .6371), but there was also no sig-
nificant differences to histamine application alone (25.0 ± 11.9/
45.8%, p = .4579).
3.6 | Histamine stimulates microglial phagocytic
activity via Hrh1
To study the effect of brain histamine on microglia at a more func-
tional level, we tested if and how microglia phagocytosis is modulated
by histamine. Phagocytic activity was quantified according to our pre-
viously published in situ assay (Wendt et al., 2017). Acute brain slices
from adult C57BL/6J mice were incubated for 60 min with latex
beads and the number of beads incorporated into a 3D-rendered
Iba1-labeled (microglia) volume was subsequently counted using con-
focal imaging and 3D reconstruction (Figure 5a). Per animal and condi-
tion, we quantified microglial phagocytosis in 4–5 cortical brain slices,
analyzing 4–5 randomly chosen fields of view per slice by z-stacks in
the cortex (layers I–VI). As shown in Figure 5b, baseline phagocytic
index in the cortex (1.65 ± 0.93/2.47; n = 54) was significantly
enhanced when histamine (100 μM) was co-applied together with the
beads (2.87 ± 2.14/3.87; n = 90; p < .0001). As there was only a low
percentage of cortical microglia responding to histamine with intracel-
lular Ca2+ elevations (12.1 ± 5.3%/20.0%; see Figure 2a,b), we
addressed the question if the increase in microglial phagocytosis upon
histamine incubation could be due to a stimulation of only a subpopu-
lation of microglial cells (Figure S4A), and therefore determined the
XIA ET AL. 2299
fraction of phagocyting microglia under control and histamine-
stimulating conditions. Under control conditions, on average 6.7 ± 0.6
microglial cells per view field incorporated one bead, which increased
to 12.3 ± 0.7 cells during histamine incubation (p < .0001,
Figure S4A). Comparing microglial cells incorporating two or more
beads under control and histamine-stimulating conditions led to a sim-
ilar increase (2 beads: 1.6 ± 0.3 and 4.4 ± 0.4 microglia/VF; 3 beads:
0.5 ± 0.1 and 1.6 ± 0.2 microglia/VF; 4 beads: 0.1 ± 0.1 and 0.7 ± 0.1
microglia/VF for control and histamine, respectively; p < .0001 for all
comparisons). As the total number of microglial cells within each
scanned volume (225 μm  225 μm  21 μm) was 113.3 ± 4.4
(n = 144 view fields), the histamine-induced increase in phagocytosis
was apparent in 9.2 ± 0.4% of the observed microglia which is in a
similar range like histamine-responding microglia in Ca2+ imaging
experiments.
Microglia Ca2+ responses to histamine have been similar in thala-
mus and cortex (see Figure S2B). We therefore tested if the stimula-
tion of phagocytic activity by histamine is also comparable in
thalamus. Interestingly, thalamic microglial phagocytosis was generally
at a lower level than cortical, with a phagocytic index of 0.44
F IGURE 5 Microglial phagocytosis in the cortex is stimulated by histamine via Hrh1 and P2ry12. (a) Left, representative confocal image of
Iba1-stained cortical microglia (red) together with latex beads (blue) performed on brain slices from an adult WT male mouse. Right, 3D
reconstruction of Iba1-positive microglia is shown with automatically counted phagocytosed beads (shown in red). Scale bars: 50 μm. The insert
shows the cells at higher magnification. (b) Comparison of phagocytic activity of cortical microglia under control conditions (white), in the
presence of histamine (black), in the presence of the subtype-specific histamine receptor agonists 2-PEA (Hrh1 agonist; 100 μM gray) or
amthamine (Hrh2 agonist; 10 μM; gray) or in the presence of histamine plus the subtype-specific histamine receptor antagonists cetirizine (Hrh1
antagonist; 10 μM; black) or tiotidine (Hrh2 antagonist; 10 μM; black). Phagocytic index indicates the number of incorporated beads per Iba+
volume (see material and methods). (c) Effect of P2ry12 blockade (1 μM AR-C69931) on microglial phagocytic activity under control and under
histamine (100 μM)- or 2-PEA (100 μM)-stimulating conditions. Box plots indicate the median (black line) as well as the 25%–75% (box) and 10%–
90% (whiskers) percentiles. Statistical significance was tested by a Kruskal Wallis test followed by Dunn's multiple comparisons test and is
indicated as followed: n.s., p ≥ .05; *p ≤ .05; **p ≤ .01, ***p ≤ .001. Number of mice/slices: N(Ctrl) = 6/55; N(histamine) = 6/90; N(2-PEA) = 3/34;
N(amthamine) = 3/33; N(histamine+cetirizin) = 3/44; N(histamine+tiotidine) = 2/20; N(ARC) = 3/45; N(histamine+ARC) = 3/45; N(2-PEA
+ARC) = 3/45
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± 0.15/0.59 under control conditions (n = 36; p < .0001 vs. cortex,
Figure S5). As in the cortex, a significant stimulation of phagocytosis
occurred in the presence of histamine (1.11 ± 0.63/1.42; n = 33;
p < .0001 vs. ctrl). The increase in phagocyting microglia was 11.5
± 2.0%, and not significantly different from cortex (p = .5863).
In an attempt to further study the histamine-induced stimulation
of microglial phagocytosis, we also tested the isoform-specific ago-
nists 2-PEA (100 μM; Hrh1), amthamine (10 μM; Hrh2), R-()-a-
methylhistamine dihydrobromide (αMH; 1 μM; Hrh3), or VUF 10460
(10 μM; Hrh4) in order to activate histamine receptors in a subtype-
specific manner. Interestingly, as summarized in Figure 5b, only incu-
bation with the Hrh1-specific agonist 2-PEA elevated microglial
phagocytosis in cortex (3.24 ± 2.38/3.77; n = 34; p < .0001 and
p > .9999 compared with control and histamine, respectively) whereas
there was no effect when Hrh2 were specifically activated (1.25
± 0.48/1.93; n = 33; p > .9999 vs. control, Figure 5b). There was like-
wise no effect on phagocytosis by stimulation of Hrh3 (1.67 ± 0.58/
2.01; n = 28; p < .8299 vs. control, data not shown) or Hrh4 (1.86
± 1.41/2.26; n = 15; p > .9999 vs. control, data not shown). We fur-
ther verified these results by blocking Hrh1 receptors using Cetirizin
dihydrochloride (5 μM) when slices were incubated with histamine.
Indeed, histamine-mediated stimulation of phagocytosis was
completely blocked by Hrh1 inhibition (1.45 ± 0.73/1.81; n = 44;
p > .9999 vs. control). The blockade of Hrh2 by using 10 μM tiotidine
did not affect cortical phagocytosis of microglia.
In thalamus, the Hrh subtype-specific effects on microglia phago-
cytic activity were similar to cortex (Figure S5B), with a stimulation by
2-PEA (Hrh1) that was comparable to histamine and no effects of
amthamine (Hrh2). Furthermore, only Hrh1, but not Hrh2, inhibition
prevented histamine-induced stimulation of microglial phagocytosis.
Taken together, our data demonstrate that histamine stimulates
microglial phagocytosis via Hrh1, but not by Hrh2 activation in cortex
and thalamus. Similar to acute intracellular Ca2+ elevations upon his-
tamine application, histamine incubation for 1 h increased the phago-
cytic activity also only in a subset of microglial cells.
3.7 | Stimulation of microglial phagocytic activity
by histamine is dependent on P2ry12
We finally tested if the Hrh1-dependent, histamine-evoked stimula-
tion of microglial phagocytosis is dependent on putatively secondary
purinergic signals. AR-C69931 was used to block microglial P2ry12
receptors during the 1 h incubation with the beads. As shown in
Figure 5c, ARC-69931 indeed completely inhibited histamine-
stimulated phagocytosis in cortex. The phagocytic index in the pres-
ence of histamine together with AR-C69931 was 0.7 ± 0.28/1.61
(n = 45) and therefore significantly lower than with histamine alone
(2.87 ± 2.14/3.99; n = 90; p < .0001) as well as similar to baseline
phagocytic activity under control conditions (1.65 ± 0.92/2.51;
n = 54; p = .3631) or in the presence of AR-C69931 alone (0.98
± 0.29/1.56; n = 54; p > .9999). Similarly, the stimulating effect of the
Hrh1-specific agonist 2-PEA (100 μM; 3.24 ± 2.35/4.06) was
completely abolished by AR-C69931 (0.75 ± 0.43/1.92; n = 45;
p < .0001 vs. 2-PEA alone). In thalamus, the Hrh1-dependent stimula-
tion of microglia phagocytosis was also abolished by AR-C69931
(Figure S5). In the presence of the P2ry12 blocker, histamine (0.18
± 0.07/0.44; n = 36) did not potentiate microglia phagocytic activity,
suggesting that the cellular and molecular mechanisms of the stimula-
tion are not different from cortex. Taken together, our data suggest
that histamine-evoked stimulation of microglial phagocytosis depends
on microglial P2ry12 receptors in cortex and thalamus.
4 | DISCUSSION
Tonic brain histamine levels are controlled by histaminergic neurons
in the tuberomammillary nucleus (TMN) in a circadian fashion and
have an impact on various brain pathologies. In the present study, we
investigated which receptors and pathways are involved in microglial
histamine responses. In freshly isolated microglia, only the Hrh2-
specific agonist amthamine did evoke intracellular Ca2+ elevations
while agonists of other subtypes of histaminergic receptors did not
trigger responses. Furthermore, only the blockade of Hrh2 but not of
the other Hrh isoforms did inhibit histamine responses of isolated
microglia. We therefore confirmed many previous transcriptomic
observations that microglia express Hrh2 and not histaminergic recep-
tors of the other three subtypes on a functional level (Butovsky
et al., 2014; Consortium, 2018; Grabert et al., 2016; Hickman
et al., 2013; Zhang et al., 2014).
In a tissue context, namely in cortical and thalamic brain slices,
the Hrh2-specific agonist amthamine did trigger a response, but we
found also responses upon Hrh1 activation which were even more
prominent. The transcriptomic data indicate that Hrh1 receptors are
functionally expressed by the majority of astrocytes but not in
microglia. The sensitivity of microglial Hrh1 responses to the P2ry12
inhibitor AR-C69931 strongly suggests an astrocyte to microglia com-
munication via ATP/ADP and P2ry12. We assume that activation of
Hrh1 receptors in astrocytes triggers the release of ATP/ADP which
stimulates intracellular Ca2+ elevations and phagocytic activity in
microglia via activation of P2ry12 purinergic receptors. It is well
established that these receptors are prominently expressed by
microglia and that activation of these receptors can stimulate phago-
cytosis (Elmadany, Logiacco, et al., 2020; Inoue et al., 2009; Koizumi
et al., 2007). In a recent study, we found even a significant decrease in
microglia phagocytic activity in the cortex of P91-P112 male and
female WT mice when P2ry12 was blocked. The reason why this
result could not be confirmed in the current study might be due to the
different age of the mice which was only P30–P60 here. A systematic
approach of this interesting issue still remains elusive.
The treatment of acute brain slices with amthamine did not affect
microglial phagocytic activity, suggesting that there is only little
involvement of microglia-intrinsic Hrh2 in controlling phagocytic activ-
ity. One possible biological role for microglial Hrh2 receptors could be
that Hrh2 expression is low and negligible under healthy conditions,
but that microglia become more directly sensitive to histamine under
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disease conditions as suggested by results from a previous publication
of our lab in which LPS treatment significantly increased microglia
responses to histamine in adult cultures (Pannell et al., 2014). Another
possibility would be that Hrh2 affects other microglial properties than
phagocytosis, that is, the ramification (Frick et al., 2016), or that we
oversaw potential microglia histamine responses that do not affect
intracellular Ca2+ levels (e.g., cAMP). We could also consider that his-
tamine receptors are not evenly distributed among the surface of
microglia and that Hrh2 receptors are located rather in microglial pro-
cesses than in the soma. Our Ca2+ responses are, however, dominated
by signals from soma. Hrh2 (and also P2ry12) receptors are known to
be linked to cAMP signaling pathways, and not-like Hrh1- to Ca2+.
However, it has been previously observed that GPCRs linked to Gi or
Gs proteins can also elicit intracellular Ca
2+ elevations (Elmadany, de
Almeida Sassi, et al., 2020; Kuhn et al., 2004; Pannell et al., 2014),
potentially by signaling of the Gßɤ subunits in a PLC/IP3R-dependent
fashion from internal stores (Clapham, 2007). Ca2+ elevations down-
stream of Hrh2 (Esbenshade et al., 2003) or P2ry12 (De Simone
et al., 2010; Irino et al., 2008; Jiang et al., 2017; Pausch et al., 2004)
activation were previously demonstrated. We therefore suggest that
microglial Hrh2- and P2ry12-dependent Ca2+ responses in the current
study also originate from internal release. This hypothesis would fit to
our data about the sparse responses to ATP or histamine in microglial
thin processes which are probably not equipped with endoplasmic
reticulum or other Ca2+ stores.
The ambient, average histamine concentration in the extracellular
space of the brain is considered to be in the range of 0.5 to 2 μM
(Best et al., 2017). That does not exclude that it can be significantly
higher in micro-compartments and has indeed been shown to locally
increase up to 20-fold under pathophysiological conditions (Haas &
Panula, 2003; Panula & Nuutinen, 2013). We used in the present
study a histamine concentration of 100 μM not to mimic physiological
HA level changes but rather to test for the presence of functional Hrh
isoforms on microglia and astrocytes. The physiological relevance of
our data are, thus, more on the functional expression of Hrh isoforms
and downstream cellular pathways. In the current study, we used
acute brain slices from healthy, young adult mice. Previous in vivo
data have shown that calcium signaling in microglia depends on brain
state, the inflammatory status and the activity of surrounding neurons
(Brawek & Garaschuk, 2013; Eichhoff et al., 2011; Umpierre
et al., 2020; Umpierre & Wu, 2020). Although we did not investigate
microglia histamine responses in vivo, it seems very unlikely that the
involvement of astrocytic Hrh1 and microglial P2ry12 is different in
the living brain. Furthermore, there could be alterations under disease
conditions due to pathophysiological changes in Hrh or P2ry12 recep-
tor expression levels or altered levels of ambient histamine.
In the current study we neither demonstrated nor ruled out a
functional role of microglial Ca2+ signaling in phagocytosis. However,
stimulation of Hrh1 which is functionally expressed on astrocytes,
stimulated microglial phagocytosis in a (microglial) P2ry12-dependent
fashion. Our data therefore indicate that astrocytes are required for
histamine stimulation of microglial phagocytic activity. There are sev-
eral previous reports on the impact of histamine on microglia
phagocytosis; however, there is so far no evidence for a potential
interaction of astrocytes in microglial responses. In fact, studies on
acutely isolated or cultured microglial cells, including the relatively
non-physiological cell line N9, do not contain other cell types like
astrocytes as potential source of secondary messengers (Albertini
et al., 2020; Barata-Antunes et al., 2017; Ferreira et al., 2012; Iida
et al., 2015; Rocha et al., 2016). To the best knowledge of the authors,
there are so far two studies testing the effect of histamine on micro-
glial phagocytosis under more physiological in situ or in vivo condi-
tions. One study showed that microglia phagocytosis was suppressed
by inhibition of Hrh3 in organotypic hippocampal brain slices. The
in vivo injection of the inverse Hrh3 agonist JNJ10181457 into
the prefrontal cortex, however, did only affect the LPS stimulation of
microglia phagocytic activity, but had no effect on unstimulated
microglia (Iida et al., 2017). As we did in the present study not directly
test for these conditions and brain regions, these data do not neces-
sarily contradict our results and it is quite tempting to speculate about
the differences to our results. Conceivable explanations for the
involvement of Hrh3 in Iida et al. (2017) might for instance be the high
density of neurons in the pyramidal layers of the hippocampus. Given
that Hrh3 is mainly expressed by neurons, it seems possible that
blockade of Hrh3could rather have inhibited a yet unknown neuron–
microglia communication than acting on microglia directly. In the pre-
sent study, by using in situ Ca2+ imaging, we did not find any evidence
for functional Hrh3 expression on cortical and thalamic microglia and
the transcriptomic data do also not support that hypothesis
(Figures 1d, 2d and S3C,D). In Iida et al., however, the activation of
microglia in the prefrontal cortex by LPS will have changed their
expression profile, which potentially lead to an upregulation of
microglia-intrinsic Hrh3. The second in vivo study on histamine and
microglia phagocytosis was performed by Rocha et al. (2016) who
found that stereotactical co-injection of histamine increased microglial
engulfment of phosphatidylcholine-containing liposomes in the sub-
stantia nigra, according to a stimulation of microglial phagocytic activ-
ity by histamine. This result fits well to our findings, although the
interplay between histamine and astrocytes was not tested directly. It
was actually demonstrated in the same study that histamine did also
stimulate phagocytosis of N9 microglia cultures in a Hrh1-dependent
fashion however, the comparability of N9 microglia cultures and
microglia in situ or in vivo is rather poor (Butovsky et al., 2014).
A further finding of the present study is that there are significant dif-
ferences in microglial responses to histamine between different brain
regions. Interestingly, microglia responses increased in corpus callosum
and thalamus, thus, brain regions with a larger percentage of white mat-
ter. In thalamus, there was a similar Hrh subtype-specific activation pat-
tern as in the cortex, suggesting that not the microglia-intrinsic
expression of Hrh isoforms but rather the microglia communication with
non-microglial cells could vary between different brain regions.
Histamine acts as a modulatory neurotransmitter and is linked to
the maintenance of wakefulness in the healthy brain. Abnormalities in
the histaminergic system have been associated with many brain dis-
eases like Parkinson's disease or multiple sclerosis (Panula &
Nuutinen, 2013). Microglia contribute to many physiological and
2302 XIA ET AL.
nearly all pathological processes in the CNS, and their ability to sense
histaminergic tones or stimuli via astrocytes and P2ry12 might have
an important impact on their behavior, including phagocytosis or syn-
aptic pruning. We therefore conclude that all histamine-related pro-
cesses in the brain could be potentially linked to microglial action via
purinergic pathways, and this unexpected connection might be essen-
tial for the future development of novel immune-related therapies.
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